News
Maria Molina, new Scientific Director of IDIBELL
Maria Molina will take over from Fernando Fernández Aranda as Scientific Director.
Endocrine disruptors may increase the risk of endometrial cancer
A study reveals an association between mixtures of environmental pollutants and an increased risk of developing endometrial cancer
Challenge Everesting: pedalling for glioblastoma research
The aim of this cycling challenge is to raise €4,000 for glioblastoma research through donations on the crowdfunding platform “Mi grano de arena”
Severe periodontitis quadruples the risk of developing diabetes
A close relationship between the two diseases has long been suggested, but now a team of researchers has shown that severe periodontitis increases the likelihood of diabetes fourfold
The first Innovation Conference on the Diagnosis and Treatment of Lung Cancer Patients at Bellvitge Campus takes place
During the day there will be a series of talks organised into three thematic blocks: diagnosis and extension studies, treatment of early disease and treatment of advanced cancer.
Researchers identify an immunomodulatory drug as a potential treatment for Parkinson’s disease
Astrocytes in the brains of Parkinson’s patients overexpress the inflammatory cytokine IL-6, which induces the death of dopaminergic neurons. The results have been obtained thanks to obtaining induced pluripotent stem cells from Parkinson’s patients.
Genetic testing improves diagnosis of the causes of epilepsy
Gene panel studies coordinated between IDIBELL and HUB have achieved that 28% more patients have a definitive diagnosis
IDIBELL successfully celebrates the 7th edition of the SLHam of Women Scientists
The public completely filled the Auditori Barradas to commemorate World Day of Women and Girls in Science
An anticancer drug opens a new path for the treatment of Parkinson’s
The metabolic product of an anticancer drug demonstrates potential activity in neurons derived from Parkinson’s patients and a synergistic action, together with the original drug, in prostate cancer cells.